Back to Agenda
Session 4: An Insight into Cardiovascular, Hepatic and Renal Safety Issues During Drug Risk Benefit Management
Speaker(s)
An insight into Cardiovascular, Hepatic and Renal Safety Issues During Risk Benefit Management
Vishwas Sovani
Revogenex, Inc., India
An insight into Cardiovascular, Hepatic and Renal Safety Issues During Risk Benefit Management
Milind Sardesai
Cognizant Technology Solutions India, India
GM - Medical Safety Services
An insight into Cardiovascular, Hepatic and Renal Safety Issues During Risk Benefit Management
Mangesh Kulkarni, MD
Tata Consultancy Services, India
Global Drug Safety - Physician and Head of Practice
Introduction to Medical Information and its Integration with Drug Safety
Aaron Cockell, MBA
AbbVie, United Kingdom
Medical Information Global Lead
IT Solutions for Efficient Medical Information Management
Satya S S Sagi, MBA, MSc
Techsol Life Sciences, United States
Founder & CEO
Cosmetic Vigilance
Mandar A. Kelkar
Tata Consultancy Services, India
Domain Lead, Safety Surveillance and Risk Management
Management of PV Challenges through Company Acquisitions and Mergers
Manoj Swaminathan
Piramal Enterprises Ltd, India
Chief Manager / Head Global Pharmacovigilance Center
Have an account?